INTERNATIONAL PATENT: NEOMICS PHARMACEUTICALS LLC FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING FUNCTIONAL COMPONENTS OF PD-1 SWITCH RECEPTOR AND FAS DOMINANT NEGATIVE RECEPTOR"

GENEVA, Dec. 2 -- NEOMICS PHARMACEUTICALS LLC (12358 Parklawn DriveRockville, Maryland 20852) filed a patent application (PCT/US2025/030123) for "COMBINATION THERAPIES COMPRISING FUNCTIONAL COMPONENTS OF PD-1 SWITCH RECEPTOR AND FAS DOMINANT NEGATIVE RECEPTOR" on May 20, 2025. With publication no. WO/2025/245063, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COMRIE, William A. (12358 Parklawn DriveRockville, Maryland 20852), SOFI, Mohammed H. (12358 Parklawn DriveRockville, Maryland 20852), HAO, Wenshan (12358 Parklawn ...